These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27320519)

  • 1. Does Bevacizumab Alter Vascularization Potential in Retinopathy of Prematurity?
    Isaac M; Mireskandari K; Tehrani N
    Ophthalmology; 2016 Sep; 123(9):2042-3. PubMed ID: 27320519
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravitreal bevacizumab for retinopathy of prematurity: Considerations for informed consent.
    Mireskandari K; Collins ME; Tehrani N
    Can J Ophthalmol; 2015 Dec; 50(6):409-12. PubMed ID: 26651298
    [No Abstract]   [Full Text] [Related]  

  • 3. PROGRESSIVE RETINAL DETACHMENT IN INFANTS WITH RETINOPATHY OF PREMATURITY TREATED WITH INTRAVITREAL BEVACIZUMAB OR RANIBIZUMAB.
    Yonekawa Y; Wu WC; Nitulescu CE; Chan RVP; Thanos A; Thomas BJ; Todorich B; Drenser KA; Trese MT; Capone A
    Retina; 2018 Jun; 38(6):1079-1083. PubMed ID: 28471890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotension Associated With Intravitreal Bevacizumab Therapy for Retinopathy of Prematurity.
    Wu LH; Yang YH; Lin CH; Lin YJ; Cheng CL
    Pediatrics; 2016 Feb; 137(2):e20152005. PubMed ID: 26743817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent Angiographic Abnormalities After Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.
    Shah N; Gupta MP; Chan RVP
    JAMA Ophthalmol; 2018 Apr; 136(4):436-437. PubMed ID: 29285531
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravitreal Bevacizumab for Zone II Retinopathy of Prematurity.
    Larrañaga-Fragoso P; Peralta J; Bravo-Ljubetic L; Pastora N; Abelairas-Gómez J
    J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):375-382. PubMed ID: 27537247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial evaluation of retinal vascular changes in infants treated with intravitreal bevacizumab for aggressive posterior retinopathy of prematurity in zone I.
    Padhi TR; Das T; Rath S; Pradhan L; Sutar S; Panda KG; Modi R; Jalali S
    Eye (Lond); 2016 Mar; 30(3):392-9. PubMed ID: 26584796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical vascular-fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity.
    Zepeda-Romero LC; Liera-Garcia JA; Gutiérrez-Padilla JA; Valtierra-Santiago CI; Avila-Gómez CD
    Eye (Lond); 2010 May; 24(5):931-3. PubMed ID: 19557020
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neurodevelopment in patients with retinopathy of prematurity treated with intravitreal bevacizumab. Case series].
    Martínez-García SM; Hernández-Da Mota SE; Rubio-Rangel A; Rojas-Flores I; Vieyra-López ME; Martínez-Castellanos MA; Zavala-Martínez MT; Gómez García A
    Cir Cir; 2017; 85(6):478-484. PubMed ID: 28110900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late-onset tractional fibrovascular proliferation post-intravitreal bevacizumab following treatment of retinopathy of prematurity.
    Agarwal-Sinha S; Guevara JG; Amin SM
    Can J Ophthalmol; 2018 Jun; 53(3):e99-e103. PubMed ID: 29784188
    [No Abstract]   [Full Text] [Related]  

  • 11. SHORT-TERM COMPUTER-ASSISTED QUANTIFICATION OF PLUS DISEASE AFTER TREATMENT OF TYPE 1 RETINOPATHY OF PREMATURITY WITH INTRAVITREAL BEVACIZUMAB OR RETINAL LASER PHOTOCOAGULATION.
    Cabrera MT; Chia T; Wallace DK; Ulrich JN; Freedman SF; Ding L; Gertsch KR
    Retin Cases Brief Rep; 2021 May; 15(3):314-319. PubMed ID: 30036271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurodevelopmental Outcomes in Infants with Retinopathy of Prematurity and Bevacizumab Treatment.
    Lien R; Yu MH; Hsu KH; Liao PJ; Chen YP; Lai CC; Wu WC
    PLoS One; 2016; 11(1):e0148019. PubMed ID: 26815000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopmental Outcomes Following Bevacizumab Injections for Retinopathy of Prematurity.
    Morin J; Luu TM; Superstein R; Ospina LH; Lefebvre F; Simard MN; Shah V; Shah PS; Kelly EN;
    Pediatrics; 2016 Apr; 137(4):. PubMed ID: 27244705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodevelopmental outcomes following intravitreal bevacizumab injection in Japanese preterm infants with type 1 retinopathy of prematurity.
    Arima M; Akiyama M; Fujiwara K; Mori Y; Inoue H; Seki E; Nakama T; Tsukamoto S; Ochiai M; Ohga S; Sonoda KH
    PLoS One; 2020; 15(3):e0230678. PubMed ID: 32196539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fundus Pigmentation in the Diagnosis and Treatment of Retinopathy of Prematurity.
    Fan KC; Read SP; Patel NA; Vanner EA; Al-Khersan H; Laura DM; Pakravan P; Negron CI; Berrocal AM
    Ophthalmology; 2021 Aug; 128(8):1242-1244. PubMed ID: 33383092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.
    Lepore D; Quinn GE; Molle F; Baldascino A; Orazi L; Sammartino M; Purcaro V; Giannantonio C; Papacci P; Romagnoli C
    Ophthalmology; 2014 Nov; 121(11):2212-9. PubMed ID: 25001158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrolental Hemorrhage in Berger's Space After Intravitreal Bevacizumab Injection for Retinopathy of Prematurity.
    Shah PR; Sachan A; Chandra P
    J Pediatr Ophthalmol Strabismus; 2020 Oct; 57():e71-e73. PubMed ID: 33090229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and Neuroimaging Changes After Bevacizumab for Retinopathy of Prematurity.
    Twitty G; Weiss M; Albayram MS; O'Mara K; Mowitz ME
    Pediatrics; 2020 Jan; 145(1):. PubMed ID: 31806670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rare association of intravitreal bevacizumab injection with double ridge formation in retinopathy of prematurity.
    Yaz Y; Erol N; Gursoy H; Basmak H; Bilgec MD
    J Pediatr Ophthalmol Strabismus; 2014 Oct; 51 Online():e66-8. PubMed ID: 25333243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral Total Cataract After Intravitreal Bevacizumab Injection in Aggressive Posterior Retinopathy of Prematurity.
    Khokhar S; Chandra P; Gupta Y; Kumawat D; Dhull C
    J Pediatr Ophthalmol Strabismus; 2019 Mar; 56():e28-e30. PubMed ID: 30907975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.